Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions - Concepedia

Concepedia

Publication | Open Access

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

DOI Full Paper Access

460

Citations

25

References

2003

Year

Asher Chanan‐Khan, János Szebeni, Sándor Sávay, Leonard Liebes, NAILA RAFIQUE, Carl R. Alving, Franco M. Muggia

Annals of Oncology

InflammationDrug HypersensitivityComplement SystemAllergyImmunotoxicologyMedicineImmunologyLiposomal DoxorubicinFirst ExposureTolerance InductionImmunotherapyDrug AllergyComplement ActivationHypersensitivity

References

	Year	Citations

Page 1

Page 1